Moderna
MRNA
#270
Rank
NZ$160.06 B
Marketcap
NZ$400.93
Share price
14.21%
Change (1 day)
733.47%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

ESG Reports

Thumbnail Moderna
 ESG Report 2023

ESG Report 2023

Language: English

View ESG Report
Thumbnail Moderna
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report